FDA Approval closer with Aptar in our corner, page-7

"The next question is what is the size of the USA market? Will it generate revenue of $1b or $3b or more ? If sale are $3b the EBITDA is potentially $2.5b"

To reach $3bill in the US, it would need to reach 100% of all sales in the US - and the US market would first need to grow another 50%.
Total sales globally are around $4bill. US sales are $2bill.
We all like the big potential but asking if it could reach 150% market share is getting a bit carried away!

"By Region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. North America Erectile Dysfunction Drugs market accounted for USD 1.92 billion in 2022 and is expected to exhibit a significant CAGR growth during the study period."

https://www.marketresearchfuture.com/reports/erectile-dysfunction-drugs-market-1313#:~:text=By%20Region%2C%20the%20study%20provides,growth%20during%20the%20study%20period.